Compare LTRN & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTRN | RMCO |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.8M | 37.9M |
| IPO Year | 2020 | N/A |
| Metric | LTRN | RMCO |
|---|---|---|
| Price | $2.79 | $2.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 151.2K | 7.4K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 0.35% |
| EPS Growth | ★ 18.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $209.10 |
| Revenue Next Year | N/A | $133.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $1.28 |
| 52 Week High | $5.74 | $5.00 |
| Indicator | LTRN | RMCO |
|---|---|---|
| Relative Strength Index (RSI) | 38.32 | 49.25 |
| Support Level | $2.49 | $2.17 |
| Resistance Level | $3.79 | $2.62 |
| Average True Range (ATR) | 0.27 | 0.20 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 9.91 | 48.89 |
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Royalty Management Holding Corp is formed to invest or purchase assets that have near and medium-term income potential to provide RMC with accretive cash flow from which it can reinvest in new assets or expand cash flow from those existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.